116 related articles for article (PubMed ID: 37572408)
21. Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA.
Kevin RC; Wood KE; Stuart J; Mitchell AJ; Moir M; Banister SD; Kassiou M; McGregor IS
J Psychopharmacol; 2017 Jun; 31(6):757-769. PubMed ID: 28093016
[TBL] [Abstract][Full Text] [Related]
22. Neuropsychiatric Sequelae in Adolescents With Acute Synthetic Cannabinoid Toxicity.
Anderson SAR; Oprescu AM; Calello DP; Monte A; Dayan PS; Hurd YL; Manini AF;
Pediatrics; 2019 Aug; 144(2):. PubMed ID: 31285395
[TBL] [Abstract][Full Text] [Related]
23. Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterases.
Wagmann L; Stiller RG; Fischmann S; Westphal F; Meyer MR
Arch Toxicol; 2022 Oct; 96(10):2755-2766. PubMed ID: 35788413
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs.
Sparkes E; Boyd R; Chen S; Markham JW; Luo JL; Foyzun T; Zaman H; Fletcher C; Ellison R; McGregor IS; Santiago MJ; Lai F; Gerona RR; Connor M; Hibbs DE; Cairns EA; Glass M; Ametovski A; Banister SD
Front Psychiatry; 2022; 13():1010501. PubMed ID: 36245876
[TBL] [Abstract][Full Text] [Related]
25. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.
Banister SD; Longworth M; Kevin R; Sachdev S; Santiago M; Stuart J; Mack JB; Glass M; McGregor IS; Connor M; Kassiou M
ACS Chem Neurosci; 2016 Sep; 7(9):1241-54. PubMed ID: 27421060
[TBL] [Abstract][Full Text] [Related]
26. Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA-parent compounds and metabolite identification in blood, urine and cerebrospinal fluid.
Tokarczyk B; Jurczyk A; Krupińska J; Adamowicz P
Forensic Sci Med Pathol; 2022 Dec; 18(4):393-402. PubMed ID: 35699867
[TBL] [Abstract][Full Text] [Related]
27. Clinical Characteristics of Synthetic Cannabinoid Use in a Large Urban Psychiatric Emergency Setting.
Manseau MW; Rajparia A; Joseph A; Azarchi S; Goff D; Satodiya R; Lewis CF
Subst Use Misuse; 2017 May; 52(6):822-825. PubMed ID: 28156305
[TBL] [Abstract][Full Text] [Related]
28. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
[TBL] [Abstract][Full Text] [Related]
29. Effect of new legislation in Germany on prevalence and harm of synthetic cannabinoids.
Sommer MJ; Halter S; Angerer V; Auwärter V; Eyer F; Liebetrau G; Ebbecke M; Hermanns-Clausen M
Clin Toxicol (Phila); 2022 Oct; 60(10):1130-1138. PubMed ID: 36074033
[TBL] [Abstract][Full Text] [Related]
30. Suicide by vaping the synthetic cannabinoid 4F-MDMB-BINACA: cannabinoid receptors and fluoride at the crossroads of toxicity?
Van Rafelghem B; Covaci A; Anseeuw K; van Nuijs ALN; Neels H; Mahieu B; Jacobs W
Forensic Sci Med Pathol; 2021 Dec; 17(4):684-688. PubMed ID: 34542803
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and
Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
[TBL] [Abstract][Full Text] [Related]
32. Synthetic cannabinoid "Black Mamba" infidelity in patients presenting for emergency stabilization in Colorado: a P SCAN Cohort.
Brandehoff N; Adams A; McDaniel K; Banister SD; Gerona R; Monte AA
Clin Toxicol (Phila); 2018 Mar; 56(3):193-198. PubMed ID: 28862050
[TBL] [Abstract][Full Text] [Related]
33. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
[TBL] [Abstract][Full Text] [Related]
34. Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19).
Institóris L; Kovács K; Sija É; Berkecz R; Körmöczi T; Németh I; Elek I; Bakos Á; Urbán I; Pap C; Kereszty É
Clin Toxicol (Phila); 2022 Jan; 60(1):18-24. PubMed ID: 34080493
[TBL] [Abstract][Full Text] [Related]
35. Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center.
Katz KD; Leonetti AL; Bailey BC; Surmaitis RM; Eustice ER; Kacinko S; Wheatley SM
West J Emerg Med; 2016 May; 17(3):290-4. PubMed ID: 27330661
[TBL] [Abstract][Full Text] [Related]
36. Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review.
de Oliveira MC; Vides MC; Lassi DLS; Torales J; Ventriglio A; Bombana HS; Leyton V; Périco CA; Negrão AB; Malbergier A; Castaldelli-Maia JM
Brain Sci; 2023 Jun; 13(7):. PubMed ID: 37508922
[TBL] [Abstract][Full Text] [Related]
37. Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones.
Khullar V; Jain A; Sattari M
J Gen Intern Med; 2014 Aug; 29(8):1200-4. PubMed ID: 24553958
[TBL] [Abstract][Full Text] [Related]
38. Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.
Lobato-Freitas C; Brito-da-Costa AM; Dinis-Oliveira RJ; Carmo H; Carvalho F; Silva JP; Dias-da-Silva D
Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33669071
[TBL] [Abstract][Full Text] [Related]
39. The Chameleon-Like Properties of Psychoactive Drugs: Examinations with HR LC-MS/MS Technology of Patients Presenting at the Emergency Department Following the Use of Synthetic Cannabinoids: A Case Series and Literature Review.
Altintop I; Karakukcu C
Behav Sci (Basel); 2018 Sep; 8(10):. PubMed ID: 30248995
[TBL] [Abstract][Full Text] [Related]
40. Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations.
Lam RPK; Tang MHY; Leung SC; Chong YK; Tsui MSH; Mak TWL
Clin Toxicol (Phila); 2017 Aug; 55(7):662-667. PubMed ID: 28393558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
